|12 Months Ended|
Dec. 31, 2017
The Company holds 8,563,254 shares of Wize Pharma Inc. (formally known as OphthaliX) as of December 31, 2017 which as of such date represents 8.2% percent of Wize Pharma Inc's outstanding shares. The shares are classified as financial asset as designated at fair value through profit or loss.
The entire disclosure for investment property.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef